Our previous results have shown increased expression of VASH2 in pancreatic ductal adenocarcinoma tissues versus matched tumor‐adjacent benign tissues by immunohistochemistry staining.13 We have confirmed this finding using qRT‐PCR (data not shown). This evidence concerns the gene VASH2 and pancreatic ductal adenocarcinoma.